InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,249.80
(
0.25%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 60
Posts 11512
Boards Moderated 0
Alias Born 07/16/2006

jbog

Member Level

Re: ronpopeil post# 228254

Tuesday, 01/14/2020 4:40:05 PM

Tuesday, January 14, 2020 4:40:05 PM

Post# of 252302
FDA advisory groups thumbs down on Nektar's oxycodegol

The vote at today's joint FDA advisory committee meeting was 27 - 0 against approval of Nektar Therapeutics' (NASDAQ:NKTR) oxycodegol for chronic low back pain.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up